Blueprint Medicines Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	310.74	209.92	110.04	101.59	170.33	65.99
Cash & Short-Term Investments	310.74	209.92	110.04	101.59	170.33	65.99
Cash Growth	146.84%	90.77%	8.32%	-40.36%	158.11%	-
Accounts Receivable	36.06	32.37	38.56	29.05	16.45	11.85
Other Receivables	14.46	10.56	2.84	8.19	8.76	0.9
Receivables	50.52	42.94	41.4	37.24	25.21	12.75
Inventory	566.55	635.87	495.51	518.11	295.06	202.69
Prepaid Expenses	44.3	17.92	18.81	13.42	6.15	3.68
Other Current Assets	3.35	1.91	1.78	1.94	2.57	16.87
Total Current Assets	975.46	908.56	667.54	672.29	499.31	301.97
Property, Plant & Equipment	1,728	1,778	1,540	1,421	1,078	871.75
Long-Term Investments	94.46	90	93.06	61.12	-	-
Other Intangible Assets	24.89	28.73	31.08	21.12	25.94	24.17
Long-Term Accounts Receivable	-	-	-	-	0.75	-
Long-Term Deferred Tax Assets	9.61	10.56	7.15	5.88	3.31	3.35
Other Long-Term Assets	68.1	57.29	51.82	48.21	40.07	34.06
Total Assets	2,901	2,873	2,390	2,230	1,648	1,235
Accounts Payable	220.75	230.93	177.99	251.26	203.45	80.13
Accrued Expenses	-	96.99	89.7	73.44	56.05	28.91
Short-Term Debt	-	-	100	110	80	130
Current Portion of Long-Term Debt	-	3.22	26.67	41.3	9.76	-
Current Portion of Leases	242.51	241.08	204.45	184.33	138.28	117.49
Current Income Taxes Payable	6.48	2.8	0.73	0.16	0.09	0.02
Current Unearned Revenue	18.07	15.73	14.28	15.74	11.88	9.33
Other Current Liabilities	208.18	72.61	63.4	54.23	63.35	20.11
Total Current Liabilities	696	663.36	677.21	730.45	562.85	385.98
Long-Term Debt	3.68	5.42	17.78	68.45	18.64	-
Long-Term Leases	1,209	1,234	1,072	1,011	761.42	608.95
Long-Term Deferred Tax Liabilities	1.9	2.12	0.59	0.52	-	-
Other Long-Term Liabilities	14.96	14.04	6.09	5.16	4.35	3.68
Total Liabilities	1,926	1,919	1,773	1,816	1,347	998.61
Common Stock	436.3	436.3	399	356	321	321
Additional Paid-In Capital	355.51	353.86	115	11.1	-	170.28
Retained Earnings	173.89	163.13	102.2	45.8	-20.91	-255.23
Comprehensive Income & Other	8.73	-	0.5	0.5	0.26	0.65
Total Common Equity	974.42	953.29	616.7	413.39	300.35	236.69
Minority Interest	0.46	0.41	0.43	0.4	-	-
Shareholders' Equity	974.89	953.7	617.13	413.8	300.35	236.69
Total Liabilities & Equity	2,901	2,873	2,390	2,230	1,648	1,235
Total Debt	1,456	1,484	1,421	1,415	1,008	856.44
Net Cash (Debt)	-1,145	-1,274	-1,311	-1,314	-837.78	-790.45
Net Cash Per Share	-25.93	-30.17	-32.96	-38.18	-25.59	-26.17
Filing Date Shares Outstanding	44.47	44.5	40.7	36.31	32.74	30.2
Total Common Shares Outstanding	44.47	44.5	40.7	36.31	32.74	30.2
Working Capital	279.47	245.2	-9.68	-58.17	-63.53	-84.01
Book Value Per Share	21.91	21.42	15.15	11.38	9.17	7.84
Tangible Book Value	949.54	924.56	585.62	392.27	274.41	212.52
Tangible Book Value Per Share	21.35	20.78	14.39	10.80	8.38	7.04
Machinery	-	132.3	116.01	93.66	455.64	98.3
Construction In Progress	-	0.39	7.08	2.61	1.36	-
Leasehold Improvements	-	553.3	456.27	374.41	4.63	290.98

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.